Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 5/20 | 0.37 |
| ▸ | CTSS | P25774 | 10/20 | 0.35 |
| ▸ | KIF11 | P52732 | 3/20 | 0.33 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3802265 | 1.00 | FFAR4 (0.37) | FFAR4CTSSKIF11ABCB11 | |
| SCHEMBL3797334 | 0.91 | FFAR4 (0.34) | FFAR4CTSSKIF11ABCB11 | |
| SCHEMBL3798425 | 0.91 | FFAR4 (0.34) | FFAR4CTSSKIF11ABCB11 | |
| SCHEMBL3798932 | 0.90 | CTSS (0.36) | FFAR4CTSSABCB11 | |
| SCHEMBL3798003 | 0.90 | CTSS (0.36) | FFAR4CTSSABCB11 | |
| SCHEMBL3803532 | 0.87 | KIF11 (0.42) | CTSSKIF11ABCB11 | |
| SCHEMBL3801236 | 0.87 | KIF11 (0.42) | CTSSKIF11ABCB11 | |
| SCHEMBL3797948 | 0.87 | FFAR4 (0.37) | FFAR4CTSSABCB11 | |
| SCHEMBL3803020 | 0.87 | FFAR4 (0.37) | FFAR4CTSSABCB11 | |
| SCHEMBL3803547 | 0.86 | CTSS (0.36) | FFAR4CTSSABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2440521-B1 | NOVEL CYCLOPENTANE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2014-04-30 | — | — | EP | claimed |
| US-20100317647-A1 | NOVEL CYCLOPENTANE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2010-12-16 | — | — | US | claimed |
| EP-2440521-B1 | NOVEL CYCLOPENTANE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2014-04-30 | — | — | EP | disclosed |
| US-20100317647-A1 | NOVEL CYCLOPENTANE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2010-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317647-A1 | NOVEL CYCLOPENTANE DERIVATIVES | TBXA2R, ADORA1, CNR1 | FFAR4 1618/4885CTSS 2367/4885KIF11 2764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.